Uncategorized

From the “Hermès of the Antioxidant” to Global Inclusivity: GeneIII Biotech Rewrites Industrial Rules On February 25, 2025, GeneIII Biotech and Professor Barry Halliwell, an international authority on anti-aging, the founder of the free radical theory of aging, and the “Father of L-Ergothioneine Research,” officially launched the L-Ergothioneine scientific research cooperation agreement at the National University of Singapore.

Recently, the opening ceremony of Nanjing University’s EMBA and International EMBA programs, along with the EMBA Strategic Development Seminar, was grandly held at the university’s Business School. Ding Wei, the founder and chairman of GeneIII Biotech, was reappointed as an EMBA lecturer at Nanjing University. As a representative industry mentor for Nanjing University’s master’s students,

Recently, the 6th CMC-China Pharmaceutical Industry Expo (referred to as the “Pharmaceutical Expo”), jointly organized by Pharma Circle, the China Food and Drug Promotion Committee, and Shangshuai Business School, successfully concluded at the Suzhou International Expo Center. Concurrently, the CMC China Synthetic Biology “Scientist + Entrepreneur + Investor” Conference, hosted by Synbio Shenbo, was also

Recently, the highly anticipated Fifth Time Pie Aging Intervention Forum concluded successfully in Shanghai. This grand event brought together over 1,000 anti-aging experts, scholars, and industry leaders, including renowned Singapore anti-aging advisor Brian Kennedy, Barry Halliwell (the father of free radical aging and ergothioneine theory), British billionaire and industry leader Jim Mellon, and Phil Newman,

Recently, the 2nd Synthetic Biology Industry Conference&Exhibition 2024 (SBC2024), organized by the Office of Development and Management of the Life Health Industry in Jiangbei New District of Nanjing, and endorsed by the Chinese Society for Microbiology, was successfully concluded at the Yangtze River International Conference Center in Nanjing. With the theme “Building for Knowledge, Building

Recently, the highly anticipated 2024 Personal Care and Homecare Ingredients Exhibition (PCHi2024) and the 27th Food Ingredients China (FIC) concluded successfully in Shanghai. GeneIII®, as a leading international manufacturer of Ergothioneine raw materials and a pioneer in the field of synthetic biology in raw material preparation, showcased its mitochondrial-grade antioxidant and “cosmetics and food from

Recently, the international ergothioneine raw material supplier—GeneIII, was selected for the China Brand Innovation Development Project and was successfully chosen as the synthetic biology industry partner for CCTV’s “Quality China” program. In just two years, GeneIII achieved the cGMP pharmaceutical-grade mass production of high-purity ergothioneine, a potent antioxidant raw material that was once as valuable

Recently, the “2024 Jiangsu Province New Year Health Poetry and Music Festival” themed “Life is like a song, walking towards the light”, guided by the Jiangsu Provincial Committee of the Cyberspace Administration, Jiangsu Provincial Health Commission, hosted by Xinhua News Agency Media Group and Jiangsu Hospital Association, and organized by Xinhua Daily Press Health Media

On February 8th, the 2023 Cosmetics Developers Conference and the inaugural Beauty Product Manager Festival, which gathered over 200 beauty brand founders, 2000+ chief scientists, product managers, formulation experts, and R&D engineers, was successfully held in Hangzhou. At this grand event, GeneIII stood out among over 200 competing ingredients and won the “Outstanding China Ingredient”

In recent years, the development momentum of ergothioneine is thriving. According to publicly available data, the global market size of ergothioneine is expected to reach $389 million by 2030, with a CAGR of 38%. Based on the powerful antioxidant properties of ergothioneine at the mitochondrial level and confirmed safety assessment by the European Commission, which